HOME >> MEDICINE >> NEWS
GroPep licenses technology to TGR BioSciences

GroPep announced today it has licensed its Whey Growth Factor Extract (WGFE) technology to Australian biotechnology company, TGR BioSciences (TGR).

TGR has raised $3 million to fund further clinical development of WGFE as a treatment for oral mucositis, a debilitating side effect of cancer treatments.

GroPep will receive royalties of more than 10% on TGR's commercialisation of the technology.

Biopharmaceutical company GroPep Limited (ASX: GRO) today announced that it has licensed certain Whey Growth Factor Extract (WGFE) technology rights to TGR BioSciences Pty Ltd (TGR). This arrangement will also allow TGR to raise additional funds to finance further development of the technology.

Under two separate agreements, venture capitalist Nanyang Innovation Fund managed by Nanyang Ventures (Nanyang) will invest up to $3 million, TGR will start a clinical trial of WGFE for oral mucositis and GroPep will license the WGFE technology to TGR.

GroPep will receive royalties of more than 10% from TGR on commercialisation of the technology and TGR has taken over responsibility for five patent families developed by GroPep and the related costs. GroPep's shareholding in TGR is reduced from 20% to 12%.

Among the rights licensed to TGR is GroPep's oral mucositis product technology. Oral mucositis is an extremely painful side effect afflicting chemotherapy patients. GroPep and collaborators have previously generated significant preclinical and clinical data, including a successful Phase 1b trial conducted at the Peter MacCallum Cancer Centre in Melbourne, indicating the safety and potential for WGFE to treat this condition. TGR has committed to initiate further clinical development in the oral mucositis setting within the next year.

Mr Gregory Moss-Smith, Vice President of Commercial Operations at GroPep, said "Licensing the technology to TGR, combined with the capital injection from Nanyang, is an effective means of advancing
'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. GroPep to pursue promising asthma drug following preclinical study results
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Doctors working overseas face having licenses removed
7. UW licenses innovated cardiovascular software to VPDiagnostics
8. The Wistar Institute licenses rubella vaccine seed stock to Microgen of Russia
9. MCW Research Foundation licenses invention for stroke treatment
10. Wireless technology shows promise in diagnosing pediatric intestinal disease
11. Speeding up CT scans with cellphone technology, ultrasound warning signal for breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 14, 2019 , ... GreenTheVoteOk , one of the ... again tried to bring the most relevant and important developments in the fast-changing world ... increasingly large number of people across the world suffering from different difficult-to-treat ailments, people ...
(Date:9/11/2019)... Pa. (PRWEB) , ... September 12, 2019 , ... “Heart ... living with diagnosed coronary artery disease as he hopes to prevent anyone from having ... creation of published author John Saltwick, a writer who was diagnosed with coronary artery ...
(Date:9/11/2019)... ... 11, 2019 , ... A September 2 article on CBS News ... significantly less likely to suffer heart attacks, strokes, kidney failure, and heart disease versus ... weight loss surgery specialists Dr. Feiz and Associates says the study adds further evidence ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... will be held September 11-14 in Minneapolis at the Mall of America Radisson ... LaPrade, will be faculty members for the high-profile, knee-focused conference, which brings together ...
(Date:9/11/2019)... DANBURY, Conn. (PRWEB) , ... September 11, 2019 , ... ... helps couples and individuals grow their family, will host a free informational event that ... and a food truck meal voucher for the first fifty registrants. The event, “What’s ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... BOSTON (PRWEB) , ... September 13, 2019 , ... ... provider of teledentistry services for employers, became the first commercial teledentistry practice in ... an award-winning startup with other hub entrepreneurs, company leaders, innovators and industry experts ...
(Date:9/14/2019)... ... ... The Allergenic Products Advisory Committee of the Food and Drug Administration (FDA) ... approval of a standardized oral immunotherapy (OIT) product for peanut allergy. The brand name ... The FDA would require a Risk Evaluation and Mitigation Strategy (REMS) to be developed ...
(Date:9/12/2019)... ... ... Stratosphere Networks will sponsor GRIN2B Foundation’s first cocktail reception fundraiser, Gather ... Kitchen and Social House in Evanston from 6 p.m. to 9 p.m. , Proceeds ... gene on the short arm of the 12th chromosome and is part of a ...
Breaking Medicine Technology:
Cached News: